Efficient Nose-to-Lung Aerosol Delivery with an Inline DPI Requiring Low Actuation Air Volume
- PMID: 30132207
- PMCID: PMC7253151
- DOI: 10.1007/s11095-018-2473-7
Efficient Nose-to-Lung Aerosol Delivery with an Inline DPI Requiring Low Actuation Air Volume
Abstract
Purpose: To demonstrate efficient aerosol delivery through an in vitro nasal model using a dry powder inhaler (DPI) requiring low actuation air volumes (LV) applied during low-flow nasal cannula (LFNC) therapy.
Methods: A previously developed LV-DPI was connected to a LFNC system with 4 mm diameter tubing. System connections and the nasal cannula interface were replaced with streamlined components. To simulate nasal respiration, an in vitro nasal model was connected to a downstream lung simulator that produced either passive or deep nasal respiration. Performance of a commercial mesh nebulizer system was also considered.
Results: For the optimized system, steady state cannula emitted dose was 75% of the capsule loaded dose. With cyclic nasal breathing, delivery efficiency to the tracheal filter was 53-55% of the loaded dose, which was just under the design target of 60%. Compared with a commercially available mesh nebulizer, the optimal LV-DPI was 40-fold more efficient and 150 times faster in terms of delivering aerosol to the lungs.
Conclusions: The optimized LV-DPI system is capable of high efficiency lung delivery of powder aerosols through a challenging nasal cannula interface.
Keywords: Dry powder inhaler (DPI); inline DPI; low flow nasal cannula; low flow oxygen; nasal cannula aerosol; pharmaceutical aerosol.
Figures






Similar articles
-
Application of an inline dry powder inhaler to deliver high dose pharmaceutical aerosols during low flow nasal cannula therapy.Int J Pharm. 2018 Jul 30;546(1-2):1-9. doi: 10.1016/j.ijpharm.2018.05.011. Epub 2018 May 5. Int J Pharm. 2018. PMID: 29733972 Free PMC article.
-
Efficient Nose-to-Lung (N2L) Aerosol Delivery with a Dry Powder Inhaler.J Aerosol Med Pulm Drug Deliv. 2015 Jun;28(3):189-201. doi: 10.1089/jamp.2014.1158. Epub 2014 Sep 5. J Aerosol Med Pulm Drug Deliv. 2015. PMID: 25192072 Free PMC article.
-
Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children.J Aerosol Med Pulm Drug Deliv. 2020 Apr;33(2):83-98. doi: 10.1089/jamp.2019.1540. Epub 2019 Aug 29. J Aerosol Med Pulm Drug Deliv. 2020. PMID: 31464559 Free PMC article.
-
Dry powder aerosol delivery systems: current and future research directions.J Aerosol Med. 2006 Spring;19(1):21-7. doi: 10.1089/jam.2006.19.21. J Aerosol Med. 2006. PMID: 16551211 Review.
-
Dry powder inhalers in COPD, lung inflammation and pulmonary infections.Expert Opin Drug Deliv. 2015 Jun;12(6):947-62. doi: 10.1517/17425247.2015.977783. Epub 2014 Nov 12. Expert Opin Drug Deliv. 2015. PMID: 25388926 Review.
Cited by
-
Development of a New Inhaler for High-Efficiency Dispersion of Spray-Dried Powders Using Computational Fluid Dynamics (CFD) Modeling.AAPS J. 2019 Feb 7;21(2):25. doi: 10.1208/s12248-018-0281-y. AAPS J. 2019. PMID: 30734133 Free PMC article.
-
Development of Dry Powder Inhaler Patient Interfaces for Improved Aerosol Delivery to Children.AAPS PharmSciTech. 2020 May 25;21(5):157. doi: 10.1208/s12249-020-01667-3. AAPS PharmSciTech. 2020. PMID: 32451773 Free PMC article.
-
Development of an effective two-equation turbulence modeling approach for simulating aerosol deposition across a range of turbulence levels.J Aerosol Sci. 2024 Jan;175:106262. doi: 10.1016/j.jaerosci.2023.106262. J Aerosol Sci. 2024. PMID: 38164243 Free PMC article.
-
Advancement of a high-dose infant air-jet dry powder inhaler (DPI) with passive cyclic loading: Performance tuning for different formulations.Int J Pharm. 2023 Aug 25;643:123199. doi: 10.1016/j.ijpharm.2023.123199. Epub 2023 Jul 4. Int J Pharm. 2023. PMID: 37406945 Free PMC article.
-
Development of an Infant Air-Jet Dry Powder Aerosol Delivery System (iDP-ADS) Including a New Multifunctional Bifurcating Two-Prong Nasal Interface.Pharm Res. 2025 Feb;42(2):365-384. doi: 10.1007/s11095-024-03814-y. Epub 2025 Feb 10. Pharm Res. 2025. PMID: 39930310 Free PMC article.
References
-
- Pornputtapitak W, El-Gendy N, Mermis J, O’Brein-Ladner A, and Berkland C. NanoCluster budesondie formulations enable efficient drug delivery driven by mechanical ventilation. International Journal of Pharmaceutics. 2014;462:19–28. - PubMed
-
- Tang P, Chan HK, Rajbhandari D, and Phipps P. Method to Introduce Mannitol Powder to Intubated Patients to Improve Sputum Clearance. Journal Of Aerosol Medicine And Pulmonary Drug Delivery. 2011;24:1–9. - PubMed
-
- Laube BL, Sharpless G, Shermer C, Sullivan V, and Powell K. Deposition of dry powder generated by solovent in Sophia Anatomical infant nose-throat (SAINT) model. Aerosol Science and Technology. 2012;46:514–520.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources